Net sales grew 2.6% year-over-year, driven by higher volumes in key segments, while profitability remained resilient despite cost inflation and geopolitical volatility. Strategic actions included a SEK 3bn share buyback and a strategic review of Consumer Tissue.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.